Learn everything you need to know about Pegfilgrastim-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...
Investigators concluded that reference or biosimilar pegfilgrastim could be safely administered to patients with lymphoma on the same day they receive chemotherapy, which could reduce scheduling ...
Amneal Pharmaceuticals this week launched its pegfilgrastim biosimilar, Fylnetra (pegfilgrastim-pbbk), for the treatment and prevention of febrile neutropenia, making it the sixth biosimilar ...
Abbreviations: AB, antibiotic prophylaxis; DOC, docetaxel; ECOG PS, Eastern Cooperative Oncology Group performance score; FEC-D, fluorouracil, epirubicin ...
New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pegfilgrastim Biosimilars Global Market Report 2023" - https://www ...
Lupin Limited announced on December 1 that it received FDA approval for its biosimilar product, ARMLUPEG (pegfilgrastim-unne). ARMLUPEG is approved as a 6 mg/0.6 mL single-dose prefilled syringe ...
Credit: Coherus. The on-body injector includes features such as a retractable needle mechanism, an indicator, status light and auditory signal to help patients confirm the dose has been administered.
Two authors (TK, MK) systematically searched electronic databases PubMed, EMBASE and CENTRAL. Databases were searched using a combination of PubMed MeSH terms and relevant search terms for ‘filgrastim ...
To compare data on severe (grade 4) neutropenia duration and febrile neutropenia incidence in patients receiving chemotherapy with pegfilgrastim administered the same day or 24 hours after ...
Review the side-effects of Pegfilgrastim as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...
Rockville , Sept. 21, 2023 (GLOBE NEWSWIRE) -- A detailed study by Fact.MR, a market research and competitive intelligence provider, states that the global pegfilgrastim biosimilars market is valued ...
Over the past several weeks, there have been numerous developments in U.S. patent litigation activity relating to biosimilars of Neupogen® (filgrastim) and Neulasta® (pegfilgrastim). Below is a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results